butyric acid and bortezomib

butyric acid has been researched along with bortezomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angiolillo, C; Cirone, M; D'Orazi, G; Faggioni, A; Gilardini Montani, MS; Granato, M	1

Other Studies

1 other study(ies) available for butyric acid and bortezomib

Article	Year
Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1. Viruses, 2018, 12-24, Volume: 11, Issue:1 Topics: Antineoplastic Agents; Bortezomib; Butyric Acid; Cell Line, Tumor; Down-Regulation; Heat Shock Transcription Factors; Herpesvirus 8, Human; Humans; Metformin; NF-E2-Related Factor 2; Quercetin; Reactive Oxygen Species; RNA-Binding Proteins; Sequestosome-1 Protein; Tetradecanoylphorbol Acetate; Trans-Activators; Transcriptional Activation; Virus Activation; Virus Latency	2018

Article

Year

Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1.

Viruses, 2018, 12-24, Volume: 11, Issue:1

Topics: Antineoplastic Agents; Bortezomib; Butyric Acid; Cell Line, Tumor; Down-Regulation; Heat Shock Transcription Factors; Herpesvirus 8, Human; Humans; Metformin; NF-E2-Related Factor 2; Quercetin; Reactive Oxygen Species; RNA-Binding Proteins; Sequestosome-1 Protein; Tetradecanoylphorbol Acetate; Trans-Activators; Transcriptional Activation; Virus Activation; Virus Latency

2018